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Neurotransmittereral distinct classes of neurons but it is still unclear how many of the functional
characteristics of these cells are speciﬁed. One of the most crucial functional characteristics of a neuron is its
neurotransmitter fate. In this paper, we show that in zebraﬁsh most glycinergic and many GABAergic spinal
interneurons express Pax2a, Pax2b and Pax8 and that these transcription factors are redundantly required for
the neurotransmitter fates of many of these cells. We also demonstrate that the function of these Pax2/8
transcription factors is very speciﬁc: in embryos in which Pax2a, Pax2b and Pax8 are simultaneously
knocked-down, many neurons lose their glycinergic and/or GABAergic characteristics, but they do not
become glutamatergic or cholinergic and their soma morphologies and axon trajectories are unchanged. In
mouse, Pax2 is required for correct speciﬁcation of GABAergic interneurons in the dorsal horn, but it is not
required for the neurotransmitter fates of other Pax2-expressing spinal neurons. Our results suggest that this
is probably due to redundancy with Pax8 and that the function of Pax2/8 in specifying GABAergic and
glycinergic neuronal fates is much broader than was previously appreciated and is highly conserved between
different vertebrates.
© 2008 Elsevier Inc.Open access under CC BY license.Introduction
The spinal cord is a crucial part of the vertebrate central nervous
system as its neuronal circuitry controls movements and receives
sensory inputs from the trunk and limbs. For this circuitry to function,
different classes of neurons have to be correctly speciﬁed in the
developing embryo. These cells form at speciﬁc dorsal/ventral
locations in the spinal cord and express particular combinations of
transcription factors (Lewis, 2006 and references therein). Currently,
we know a lot about how these cells become molecularly-distinct
from each other and express particular combinations of transcription
factors (Lewis, 2006 and references therein) but we know a lot less
about how the expression of particular transcription factors relates to
the development of speciﬁc functional neuronal characteristics.
One crucial identifying characteristic of a neuron is the neuro-
transmitter(s) that it releases. How this is determined is still not very
well understood and it is unclear whether similar or different
mechanisms operate in distinct classes of neurons. Currently,
speciﬁcation of neurotransmitter fate is best understood in the
mouse dorsal spinal cord, where Lbx1, Ptf1a, Lhx1 and Lhx5
transcription factors act upstream of Pax2 to specify GABAergic cells license.and Tlx1/3 antagonise the effects of Lbx1 to specify glutamatergic cells
(Cheng et al., 2004, 2005; Glasgow et al., 2005; Pillai et al., 2007). In
the mouse, Pax2 is also expressed in more ventral interneurons, but
the neurotransmitter fates of these cells are unchanged in Pax2 knock-
out mice (Cheng et al., 2004; Pillai et al., 2007), suggesting that Pax2
has distinct functions in different interneurons.
In the zebraﬁsh, Danio rerio, there are two pax2 genes (pax2a and
pax2b) and these both have a very similar spinal cord expression
pattern to the highly-related pax gene, pax8 (Figs. 1A, B and E; Pfeffer
et al.,1998). In this paper, we show that in zebraﬁsh the vastmajority of
glycinergic spinal interneurons express Pax2/8 as do most GABAergic
neurons within the spinal cord region where pax2/8 genes are
expressed. When we knock-down just Pax2a, Pax2b or Pax8, there is
very little effect on these glycinergic and GABAergic interneurons, but
ifwe knock-down all three of these Pax2/8 proteinsmany interneurons
lose their glycinergic and/or GABAergic fates, including the vast
majority of CiAs, which are the most ventral population of Pax2/8
expressing spinal cells.We also establish that this function of Pax2/8 in
spinal interneurons is very speciﬁc: cells lose their glycinergic and/or
GABAergic fates in triple knock-down embryos, but they do not
become glutamatergic or cholinergic. In addition, the soma morpho-
zlogies and axon trajectories of CiAs are unchanged.
Our results suggest that the limited phenotype in the Pax2mutant
mice may be due to redundancy with Pax8 and consistent with this, in
Fig. 1. Expression of pax2 and pax8 genes in zebraﬁsh spinal cord. pax2a, pax2b and pax8 are co-expressed by many cells but pax5 is not expressed in zebraﬁsh spinal cord. Lateral
views of pax2a (A), pax2b (B), pax2a and pax2b (C and D; probes were mixed), pax8 (E and F), pax5 (H and L) and pax2a and pax2b (J; pax2a in green and pax2b in red) expression in
24 h wild-type (WT) trunks (A–C, E and H) and triple-knock-down (TKD) embryos (pax2amutants injectedwith pax2b and pax8MOs) (D, F and L). pax8 staining is weaker than pax2a
and pax2b and hard to photograph. This means that several weak pax8-expressing cells are hard to see in (E). However, when pax8-expressing cells were counted, similar numbers
were obtained to when pax2a- or pax2b-expressing cells were counted (see I). (G) shows a dorsal view of the midbrain–hindbrain boundary of a 24 h wild-type embryo (a region of
the embryo where pax5 is expressed, to show that this in situ hybridisation probe works). (J) shows merged and single channel images of a 2 colour ﬂuorescent double in situ with
pax2a in green and pax2b in red. In all cases, rostral is left. In all cases except (G), dorsal is top. Scale bar=25 μm (A–H and L); 18 μm (J). (I) Average number of cells expressing pax2a,
pax2b, pax8 and pax2a, pax2b or pax8 (probes were mixed) at 24 h in 5 different WT embryos. As the number of cells expressing pax2a, pax2b, pax8 or (pax2a, pax2b or pax8) are not
statistically different from each other, these genes must be co-expressed in spinal cord cells. (K) Average number of cells expressing pax2a or pax2b (probes were mixed) in 12
uninjected noi sibs and 12 TKD embryos. In this and all other ﬁgures, cells were counted in a 5-somite length of spinal cord adjacent to somites 6–10. Cell row numbers are counted
ventral to dorsal (e.g. cells directly above the notochord are in row 1, see Supp. Data Fig. 1F). Rows not shown have a cell count of zero. None of the differences in (I) and (K) are
statistically signiﬁcant. Error bars denote standard deviation.
89M.F. Batista, K.E. Lewis / Developmental Biology 323 (2008) 88–97these mouse mutants Pax8 continues to be expressed in the ventral
spinal cord, but it is lost from the Pax2-expressing cells that migrate
into the dorsal horn (Pillai et al., 2007). This suggests that the function
of Pax2/8 in specifying glycinergic and GABAergic neuronal fates is
much broader than was previously appreciated and is highly
conserved between different vertebrates.Materials and methods
Zebraﬁsh lines
Zebraﬁsh (D. rerio) embryos were obtained from wild-type (AB,
TL, or AB/TL hybrids) or Tg(pax2a:GFP) adults (Picker et al., 2002) or
Fig. 2. Most Pax2-expressing zebraﬁsh spinal interneurons are inhibitory. Lateral views of Pax2 immunohistochemistry and in situ hybridisation for markers of glycinergic (A),
GABAergic (B) glutamatergic (C) and GABAergic or glycinergic (labelled “inhibitory”; probes were mixed) (D) cell fates in 24 h WT trunks. See Materials and methods for details of
probes used. Stars indicate double labelled cells. Rostal is left, dorsal is top. Scale bar=50 μm. (E) Percentage of Pax2-expressing cells with particular neurotransmitter phenotypes. (F
and G) Percentage of cells with speciﬁc neurotransmitter phenotypes that express Pax2 in whole spinal cord (F) or just the Pax2-expression domain (rows 4–7; G). In all cases,
percentages are averages from 5 different embryos at 24 h. Error bars denote standard deviation. Note that most glycinergic cells are found in the Pax2/8 expression domain but many
GABAergic cells are foundmore ventrally in the spinal cord (A and B; also cf. F and G). (H–J) Magniﬁed views of dashedwhite boxes in A (H), B (I) and C (J) respectively showing red and
green channels and merged images for a single confocal focal plane. Stars in merged images indicate double labelled cells. For single channel images of the whole lateral view see
Supp. Data Fig. 2.
90 M.F. Batista, K.E. Lewis / Developmental Biology 323 (2008) 88–97identiﬁed carriers heterozygous for noitu29a, a null allele of pax2a
(Lun and Brand, 1998). Embryos were staged by hours post-
fertilisation at 28.5 °C (h) and/or appropriate morphological criteria
as in Kimmel et al. (1995). noi mutants were identiﬁed by their lack
of a midbrain/hindbrain boundary (Brand et al., 1996; Lun and Brand,
1998).
In situ hybridisation and immunohistochemistry
In situ hybridisation was performed as in Concordet et al. (1996).
For double in situ hybridisation, embryos were treated with Signal
Enhancer (Invitrogen) before antibody incubation. Mouse-Anti-Dig
(1/5000, Jackson ImmunoResearch) and Rabbit-Anti-Flu (1/2500,Roche) were detected with Invitrogen Tyramide kits #12 (488) and
#5 (594). For in situ hybridisation and immunohistochemistry double
stainings, Rabbit-Anti-GFP (1/1000) fromMolecular Probes or Rabbit-
Anti-Pax2 (1/300) from BabCO was revealed with Alexa-Fluor Goat-
Anti-Rabbit 488 (1/1000) from Molecular Probes. RNA was detected
with Invitrogen Tyramide kit #5. Double immunohistochemistry
experiments to simultaneously detect Pax2 and GFP or Eng1b and
GFP utilised Mouse-Anti-GFP (1/300) from Molecular Probes (cata-
logue # A11121). Eng1b antibody was kindly provided by A. Joyner
(Skirball Institute, New York). This antibody (anti-Enhb-1; rabbit
polyclonal) was generated against the mouse En2 homeodomain and
detects both En1 and En2 in mammals (Davis et al., 1991) but only
Eng1b in zebraﬁsh (Higashijima et al., 2004b).
Fig. 3. Pax2/8 act redundantly to specify inhibitory fates. Lateral views of in situ hybridisation for markers of glycinergic (A and D), GABAergic (B and E) glutamatergic (C and F) and
acetylcholinergic (J and K) cell fates at 24 h inWT (A–C and J) and triple-knock-down (TKD) trunks (D–F and K). In (J and K) stars indicate cells expressing the acetylcholinergicmarker,
chat. In these photographs, some of the weaker cells are in a slightly different focal plane (on the other side of the spinal cord). In (B and E) the black line indicates the boundary
between dorsal GABAergic cells within the Pax2/8 expression domain (rows 4–7) andmore ventral GABAergic cells. Note that most remaining GABAergic cells in (E) are in the ventral
regionwhere Pax2/8 are not expressed and that none of the acetylcholinergic cells are within the Pax2/8 expression domain in either wild-type (J) or TKD (K) embryos. Rostal is left,
dorsal is top. Scale bar=40 μm. Immunohistochemistry for Pax2 inWT (G), noi (pax2a) mutant (H) and TKD (I) embryos. As Pax2 staining is present in (H) the antibodymust recognise
Pax2b. Therefore, lack of staining in (I) suggests that we have eliminated Pax2a+Pax2b protein in TKD embryos. (M and N) number of glycinergic and GABAergic cells at 24 h in Pax2/8
expression domain inWT, single-, double- and triple-knock-down embryos. Stars indicate statistically signiﬁcant results (pb0.05). For results inwhole spinal cord see Supp. Data Figs.
4C and C'. For results of additional single and double knock-down experiments see Supp. Data Fig. 3 and Supp. Data Tables 1 and 2. (L and O–Q) show results for control and TKD
embryos for all 4 neurotransmitters, broken down row by row. Rows not shown have a cell count of zero. In all cases, error bars denote standard deviation. The number of glycinergic
and GABAergic cells is reduced in the Pax2/8 expression domain in TKD embryos but there is no signiﬁcant change in the number of glutamatergic or acetylcholinergic cells in any
region of the spinal cord.
91M.F. Batista, K.E. Lewis / Developmental Biology 323 (2008) 88–97To determine neurotransmitter phenotypes we used in situ
hybridisation for genes that encode proteins that transport or
synthesise speciﬁc neurotransmitters. glyt2a and glyt2b (glycinergic
markers) encode for glycine transporters necessary for glycine
reuptake and transport across the plasma membrane; gad65, gad67a
and gad67b (GABAergic markers) encode for a glutamic acid
decarboxylase, necessary for the synthesis of GABA from glutamate
and vglut2.1, vglut 2.2a and vglut 2.2b (glutamatergic markers) encode
proteins responsible for transporting glutamate to the synapse. In all
of these cases, a mix of equal concentrations of the relevant probes
was used (Higashijima et al., 2004a,c). Choline acetyltransferase (chat)
encodes for an enzyme that catalyzes the synthesis of acetylcholine
(Yokogawa et al., 2007).
Other probes were pax2a, pax2b, pax8, pax5 (Pfeffer et al., 1998),
p53 (Robu et al., 2007) and eng1b (1.3 KB encompassing the ORF, akind gift from Drs. Kikuchi and Westerﬁeld at the University of
Oregon).
Photographswere taken using a Zeiss Axio ImagerM1 (DIC images)
or a Leica TS SP2 confocal (ﬂuorescent images) microscope and
processed using Adobe Photoshop. All ﬂuorescent images, with the
exception of Figs. 2H–J and Figs. 4A'– E' and I' are projections of
multiple optical sections performed in Image J (Abramoff et al., 2004).
Morpholino injections and controls
Morpholino antisense oligonucleotides (MOs) were injected into
1–2 cell embryos from a cross of identiﬁed carriers heterozygous for
noitu29a. Therefore,∼25% of injected embryos lacked Pax2a. All of these
morpholinos have been used successfully in previous studies. The
pax2b MO blocks translation and is GGTCTGCCTTACAGTGAATATCCAT
Fig. 4. Pax2/8 specify inhibitory fates in CiA interneurons. Lateral views of 24 h trunks. (A, B, D and G) WT embryos, (C, E and H) triple-knock-down (TKD) embryos, (F, I, J and L) Tg(pax2a:GFP) WT embryos (K and M) Tg(pax2a:GFP) TKD
embryos. Rostal is left, dorsal is top. (A) Pax2 (green), eng1b (red). (B–E, G and H) Double in situ hybridisation for eng1b (green) and neurotransmitter markers (red). eng1b staining is weaker in some pictures, but the same number of eng1b-
expressing cells (13.9±1.8 over a 5-somite length) were counted in each embryo (control and TKD). (F) Eng1b (red), GFP (green). The vast majority of GFP-positive cells in Tg (pax2a:GFP) embryos are CiAs and express Eng1b, although there are
also a fewmore dorsal GFP-positive cells that are not CiAs. Occasionally a weak Eng1b-expressing cell can be observed that is not yet expressing GFP. (I) Pax2 (red), GFP (green). Note that all green cells are also red but several red cells are not
green. (J–M) GFP (green). All of the ventral GFP-expressing cells are CiAs with similar ipsilateral ascending axons. (L andM) show highermagniﬁcation views of individual GFP-expressing CiAs in Tg(pax2a:GFP)WT (L) and TKD (M) embryos. For
quantiﬁcation of soma size and axon length see Supp. Data Table 3. Stars indicate double labelled cells. Scale bar=50 μm (A–E and G–I); 30 μm (F, J and K). (N) Percentage of CiAs (eng1b-expressing cells) that are glycinergic or GABAergic inWT
and TKD embryos. Each percentage is an average from 12 different embryos. Stars indicate statistically signiﬁcant results (pb0.05). Error bars denote standard deviation. No glutamatergic CiAs were observed in any embryo. (A'–E' and I') are
magniﬁed views of boxes in A–E and I respectively, showing red and green channels andmerged images for a single confocal focal plane. Stars in merged images indicate double labelled cells. For single channel images of thewhole lateral view
for A–E and I see Supp. Data Fig. 6.
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93M.F. Batista, K.E. Lewis / Developmental Biology 323 (2008) 88–97(Bricaud and Collazo, 2006; Mackereth et al., 2005; Millimaki et al.,
2007); the pax8 MOs block splicing and a combination of E5/15
(TTTCTGCACTCACTGTCATCGTGTC) and E9/19(ACCGGCGGCAGCT-
CACCTGATACCA) (Hans et al., 2004) were used.
MOswere initially injected at concentrations of 1mg/ml,1.5mg/ml
and 2mg/ml each. At 1.5 mg/ml and 2mg/ml the phenotypewasmore
severe than at 1 mg/ml (Supp. Data Figs. 4B and B'). However, at
2 mg/ml some embryos were morphologically disturbed (they had
twisted axis and wavy notochords). Therefore, in all of the experi-
ments presented in this paper, with the exception of Supplementary
Data Fig. 1B, MOs were injected at 1.5 mg/ml each. At this
concentration, triple-knock-down embryos (noi mutants injected
with pax2b and pax8 MOs) completely lost expression of pax8 RNA
and Pax2 protein (Figs. 1F and 3I), suggesting that Pax2a, Pax2b and
Pax8 were fully knocked-down. To further conﬁrm that the pax8
splice-blocking MOs were working we examined pax8 expression in
embryos injected with a lower concentration of morpholinos
(1 mg/ml). In this case, pax8 RNA was localised in the nucleus,
indicating that splicing of pax8 RNA was blocked (Yan et al., 2002; cf.
Supp. Data Figs. 1A and B).
To rule out the possibility that the phenotype observed in
morpholino injected embryos was due to either speciﬁc or non-speciﬁc
toxicity or cell death we examined p53 expression in our injected
embryos at 36 h. Non-speciﬁc cell death due to MO toxicity usually
causes an upregulation of p53 expression (Robu et al., 2007). However,
there was no expression of p53 in our injected embryos (36 h; n=60;
Supp.Data Fig.1H). In addition,wedemonstrated thatpax2/8-expressing
cells still form in morpholino injected embryos using an in situ
hybridisation forpax2a andpax2b (Figs.1D andK).We sawno signiﬁcant
changes in the number of cells expressing these genes in triple knock-
down embryos compared towild-type embryos. Therefore, the cells still
formand the reducednumberof glycinergic andGABAergic cells in triple
knock-down embryos is not due to a reduction in the number of pax2/8-
expressing cells. Finally, we also showed that CiAs, which are a speciﬁc
subset of pax2/8-expressing cells, not only form in normal numbers in
triple knock-down embryos, but their gross morphology (cell soma size,
shape and axon trajectory) is also unchanged even though the vast
majority of these cells are no longer glycinergic or GABAergic (Figs. 4J–M
and Supp. Data Table 3). Taken together, these observations suggest that
the phenotype from knocking-down Pax2/8 is very speciﬁc and is not
due to toxicity or to the cells dying.
To further conﬁrm that our results were not caused by non-speciﬁc
effects of the morpholino injections we also injected two different
morpholinos at the same total concentration (4.5 mg/ml) as our
Pax2/8 triple knock-down experiments. These morpholinos were an
evx1 translation blocking morpholino: CCTTTCCGTGCTTCGGCGAGCC-
CAT and a lis1 control morpholino: CTgGTaGCCTCTGTGACAGgACgAT
(small case letters show mismatches) which was a kind gift from
Richard Adams. We injected these morpholinos into both wild-type
embryos and into noi (pax2a) mutant embryos. In all of these
experiments there was no change in the number of glycinergic and
GABAergic spinal neurons (Supp. Data Fig. 7).
In all of our experiments, we observed a continuum of results,
presumably due to slight variations in the amount of knock-down
achieved from the MOs in different embryos and in individual cells
within injected embryos. Very occasional morphologically disturbed
embryos were excluded from further analysis. Each experiment was
repeated 3 times (∼60 embryos injected each time). Results are shown
for the 4 most severely effected embryos from each experiment (12
embryos in total).
Cell counts and statistical analyses
In all cases, cell counts are for both sides of a 5-somite length of
spinal cord adjacent to somites 6–10. Cell row numbers are assigned
ventral to dorsal (e.g. cells directly above the notochord are in row 1,see Supp. Data Fig. 1F). The Pax2-expressing spinal cord domain is
deﬁned as rows 4–7 based on results shown in Fig. 1. Results were
analysed using the students' T test. Statistically signiﬁcant results
where pb0.05 are indicated with a star in the ﬁgures and individual p
values are provided in Supp. Data Table 2. Error bars in ﬁgures indicate
the standard deviation. Results in the text are shown as the
mean±standard deviation. For all of the knock-down experiments
(morpholino injections and analysis of noi mutants) both the
experimental and control results are an average of 12 embryos. For
analyses that only include wild-types (e.g. determining the neuro-
transmitter phenotypes of Pax2-expressing cells in wild-type
embryos) results are an average of 5 different embryos.
Results
Pax2/8-expressing zebraﬁsh interneurons are predominantly glycinergic
and/or GABAergic
In 24 h zebraﬁsh embryos, pax2a, pax2b and pax8 all have very
similar expression patterns, suggesting that they are co-expressed by
several distinct interneuron populations that form initially in the
intermediate region of the spinal cord (Figs. 1A–C, E, I and J; Pfeffer
et al., 1998). Consistent with this, similar numbers of cells are labelled
by in situ hybridisation in wild-type embryos when pax2a, pax2b or
pax8 probes are hybridised either singly or together (Figs. 1A–C, E
and I) and 2-colour double in situ hybridisation for pax2a and pax2b
shows that these two genes are indeed expressed by the same spinal
cord cells (Fig. 1J). Pax2 and Pax8 are part of a subfamily of Pax
transcription factors that also includes Pax5 (Bouchard et al., 2000,
2002; Hans et al., 2004; Holland et al., 2007; Pfeffer et al., 1998; Wada
et al., 1998;Walther et al., 1991). However, pax5 is not expressed in the
zebraﬁsh spinal cord (Fig.1H; http://www.zﬁn.org; Pfeffer et al.,1998).
To determine the neurotransmitter phenotypes of zebraﬁsh pax2-
expressing interneurons we combined immunohistochemistry for
Pax2 and in situ hybridisation for markers speciﬁc for glycinergic,
GABAergic and glutamatergic cells (see Materials and methods). At
24 h, about 90% of Pax2-expressing spinal cells are either glycinergic
and/or GABAergic, with ∼60% being glycinergic and a similar
percentage GABAergic (Figs. 2A, B, D and E; 89.2%±4.7 express either
GABAergic or glycinergic markers, 57.6%±6.5 are glycinergic and
57.1%±3.6 are GABAergic; see also Supp. Data. Fig. 2). This suggests
that about a third of Pax2-expressing spinal cells express both
GABAergic and glycinergic markers at this stage. Intriguingly a small
number of Pax2-expressing spinal cells express glutamatergic
markers (Figs. 2C and E; 16.4%±1.6). These cells are predominantly
in the most dorsal row of Pax2 expression where they appear to
correspond to the larger cells that are the ﬁrst cells in the spinal cord
to express Pax2 (Mikkola et al., 1992).
Pax2-expressing interneurons account for ∼80% of the glycinergic
and ∼34% of the GABAergic interneurons in the zebraﬁsh spinal cord
(Figs. 2A, B and F; 80.4%±6.6 and 33.8%±2.9 respectively). However,
most of the GABAergic cells that do not express Pax2 are found in the
ventral spinal cord outside the Pax2-expression domain (Figs. 2B and
cf 2F and 2G). Within the intermediate spinal cord region where Pax2
is expressed (rows 4–7), ∼75% of GABAergic cells express Pax2
(Fig. 2G; 74.8%±11.7). This shows that not only are the vast majority of
Pax2-expressing spinal cells glycinergic and/or GABAergic, but in the
spinal cord region where Pax2 is expressed, most glycinergic and
GABAergic neurons express Pax2.
Pax2/8 act redundantly to specify glycinergic and GABAergic fates of
multiple interneurons in zebraﬁsh spinal cord
To determine whether Pax2 is required for glycinergic and/or
GABAergic fates in the spinal cord, we ﬁrst examined zebraﬁsh
embryos that lack Pax2a function (no isthmus (noi) mutants) at 24 h
94 M.F. Batista, K.E. Lewis / Developmental Biology 323 (2008) 88–97(Brand et al., 1996; Lun and Brand, 1998). In all cases, loss of Pax2a had
no effect on the number of cells with particular neurotransmitter
phenotypes (Figs. 3M and N; Supp. Data Fig. 3 and Supp. Data Tables 1
and 2). To test whether this is due to functional redundancy between
Pax2a and Pax2b, we knocked-down Pax2b function in noi mutants
using a pax2b morpholino (MO). At 24 h, we observed a statistically
signiﬁcant reduction in the number of glycinergic cells (Fig. 3M and
Supp. Data Tables 1 and 2) showing that Pax2 function is required for
the glycinergic fates of some spinal cord cells. However, there was no
signiﬁcant change in the number of GABAergic cells (Fig. 3N and Supp.
Data Tables 1 and 2) and the reduction in the number of glycinergic
cells was far less than the number of glycinergic interneurons that
express Pax2 (cf. Figs. 3M and 2G).
Therefore, we tested whether there was functional redundancy
between Pax2 and Pax8 by injecting MOs against pax2b and pax8 into
noi mutants. These triple knock-down embryos lost expression of
pax8 RNA (Fig. 1F) and Pax2 protein (Fig. 3I), suggesting that Pax2a,
Pax2b and Pax8 were all fully knocked-down. We also conﬁrmed that
pax5 expression was not activated in the spinal cord of these triple
knock-down embryos (Fig. 1L). Interestingly, our results show that
pax8 spinal cord expression is regulated by Pax2 and may also be
regulated by Pax8 (pax8 expression is dramatically downregulated in
the absence of either Pax2 or Pax8 function and it is completely lost in
triple knock-down embryos; see Fig. 1F, Supp. Data Figs. 1C–E and
discussion in Supp. Data Fig. 1 legend). However, in contrast pax2
expression does not require Pax2/8 function (Figs. 1D and K).
In these 24 h triple knock-down embryos, we observed a dramatic
decrease in the number of glycinergic and GABAergic spinal cord cells
in the intermediate region of the dorso-ventral axis where Pax2 is
normally expressed (Figs. 3D, E and M–P). In contrast, wild-type
embryos injected with pax8 MOs had only minor reductions in the
number of glycinergic and GABAergic cells (Supp. Data Fig. 3 and Supp.
Data Tables 1 and 2), supporting the hypothesis that pax2a, pax2b and
pax8 function redundantly in specifying glycinergic and GABAergic
fates.
We conﬁrmed that our morpholino injections were not causing
either speciﬁc or non-speciﬁc cell death by demonstrating that the
same number of cells express pax2 RNA inwild-type and triple knock-
down embryos (Figs. 1C, D and K), that there was no upregulation of
p53 (Robu et al., 2007) in triple knock-down embryos (Supp. Data
Fig. 1H) and that injection of two different control morpholinos into
wild-type or noi (pax2a) mutants had no effect on glycinergic or
GABAergic spinal neurons (Supp. Data Fig. 7; see also the longer
discussion of morpholino control experiments in Materials and
methods). In addition, we demonstrated that the reduction in the
number of glycinergic and GABAergic cells is not caused by cells
changing to a glutamatergic or acetylcholinergic fate as wild-type and
triple knock-down embryos have the same number of glutamatergic
and acetylcholinergic spinal cord cells (Figs. 3C, F, J–L and Q).
Finally, to conﬁrm that glycinergic and GABAergic fates are not just
delayed in triple knock-down embryos, we also examined wild-type
and triple knock-down embryos at 36 h and 48 h. In both cases, we
still observed a signiﬁcant reduction in the number of glycinergic and
GABAergic neurons in triple knock-down embryos compared to stage-
matchedwild-type controls (Supp. Data Figs. 4A and A' and Supp. Data
Fig. 5).
As our results are consistent with those previously reported by
other researchers in the dorsal horn of the mouse Pax2 knock-out
(Cheng et al., 2004; Pillai et al., 2007), it seems very unlikely that the
phenotypes we observe in triple knock-down embryos are due to off-
target effects from the morpholinos (i.e. to one of the morpholinos
knocking-down a different gene, that is required for glycinergic or
GABAergic fates). However, to further conﬁrm this, we examined all of
the different combinations of Pax2/8 knock-down (Supp. Data Fig. 3
and Supp. Data Table 1 and Table 2). Two observations argue strongly
that loss of glycinergic and GABAergic spinal fates is speciﬁcallycaused by knocking-down Pax2/8 function. Firstly, we see a
continuum of phenotypes depending on how many Pax2/8 proteins
we knock-down, regardless of whether we use the pax2b MO, the
pax8 MOs or the noi (pax2a) mutants (Supp. Data Fig. 3 and Supp.
Data Table 1 and Table 2). Secondly, we observe a statistically
signiﬁcant difference between wild-type embryos injected with
pax8 and pax2b morpholinos and noi mutants injected with pax8
and pax2b morpholinos (the triple knock-downs are always more
severely affected than the double knock-downs, p=0.005 in the case
of glycinergic cells and p=0.0045 in the case of GABAergic cells; see
also Supp. Data Fig. 3 and Supp. Data Table 1 and 2). If our results were
due to off-target effects from the morpholinos then this would not be
the case. We would instead expect these two results to be very similar
to each other.
Taken together, our results demonstrate that Pax2/8 are redun-
dantly required for the glycinergic and/or GABAergic fates of many
zebraﬁsh spinal cord interneurons, but that the absence of Pax2/8
function (and of a glycinergic and/or GABAergic fate) is not sufﬁcient
for cells to become glutamatergic or cholinergic.
Pax2/8 are required to specify glycinergic fates of most CiAs
In mouse, Pax2 is required for the neurotransmitter fates of dorsal
horn GABAergic neurons but it is not required for the neurotransmit-
ter fates of more ventral Pax2-expressing interneurons (Cheng et al.,
2004; Pillai et al., 2007). In contrast, our results suggest that Pax2/8
are required for GABAergic and glutamatergic fates throughout the
dorsal–ventral extent of the Pax2-expression domain. To further
conﬁrm this, we speciﬁcally examined the most ventral population of
Pax2-expressing spinal cells. In amniotes, these are V1 cells. In
zebraﬁsh, Circumferential Ascending interneurons (CiAs) (Bernhardt
et al., 1990) are thought to be homologous to V1 cells (Higashijima
et al., 2004b; Sapir et al., 2004). Both V1 cells and CiAs are the only
spinal cells to express the transcription factor Eng1b (in the case of
zebraﬁsh) or En1 (in the case of amniotes) (Higashijima et al., 2004b;
Sapir et al., 2004). In addition, both of these cell types share
morphological and functional characteristics. For example, both CiAs
and V1 cells are inhibitory, they have ipsilateral ascending axons and
they are involved in regulating fast locomotionmovements (Gosgnach
et al., 2006; Higashijima et al., 2004b; Li et al., 2004). However, before
this study, it had not been determined whether CiAs also, like V1 cells,
express Pax2.
Using in situ hybridisation for eng1b and immunohistochemistry
for Pax2 we demonstrated that at 24 h CiAs express Pax2 and that
they are indeed the most ventral spinal cord cells to do so (Fig. 4A;
see also Supp. Data Fig. 6A). Consistent with this, we also showed that
24 h embryos from a transgenic line where GFP is regulated by a
partial pax2 promoter (Picker et al., 2002), express GFP in a subset of
spinal cord Pax2-expressing cells, the majority of which are CiAs
(Figs. 4F and I–M).
Determining that CiAs express Pax2 provided us with the
opportunity not only to investigate the effects of Pax2/8 knock-
down on the most ventral population of Pax2/8-expressing spinal
neurons, but also to examine the morphology and neurotransmitter
phenotypes of a single identiﬁed class of neurons. Our more global
analysis of triple knock-down embryos identiﬁed a dramatic decrease
in the number of glycinergic and GABAergic cells in the intermediate
region of the spinal cord where Pax2/8 are normally expressed
(Figs. 3D, E and M–P). However, some glycinergic and GABAergic cells
still remain in these triple knock-down embryos and it was unclear
whether this was due to incomplete penetrance of the phenotype or
due to Pax2/8 only being required for the glycinergic and/or
GABAergic fates of speciﬁc subsets of Pax2/8-expressing neurons.
Determining the phenotype of CiAs in triple knock-down embryos
should enable us to distinguish between these two possibilities. In the
former case, we would expect some CiAs to maintain their glycinergic
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latter case we would expect all CiAs to have the same phenotype
(either loss of glycinergic and GABAergic fates or no effect).
At 24 h, ∼90% of CiAs are glycinergic and just over 40% are
GABAergic, suggesting that several CiAs express both of these
neurotransmitters at this stage (Figs. 4B, D and N; 89.52%±6.87 of
CiAs are glycinergic and 42.59%±5.04 are GABAergic; see also Supp.
Data Fig. 6 and Higashijima et al., 2004b). Consistent with our analyses
of whole spinal cords, in triple knock-down embryos the number of
CiAs (eng1b-expressing cells) is not altered, but the number of
glycinergic and GABAergic CiAs is reduced (Figs. 4C, E and N; in triple
knock-down embryos only 23.52%±5.43 of CiAs are glycinergic and
27.69%±6.86 are GABAergic; see also Supp. Data Fig. 6). However, no
CiAs are glutamatergic, in either wild-type or triple knock-down
embryos (Figs. 4G and H) and the general size and shape of CiA somata
and CiA axon lengths and trajectories are indistinguishable in wild-
type and triple knock-down embryos (Figs. 4J–M and Supp. Data
Table 3). This suggests that the loss of glycinergic and GABAergic fates
is a very speciﬁc phenotype and that in other respects these cells
develop normally (at least at these early stages).
These results also suggest that the incomplete penetrance of the
Pax2/8 knock-down phenotype is not due to speciﬁc Pax2/8-
expressing populations being resistant to loss of Pax2/8 function.
CiAs are thought to constitute a single class of neurons (Higashijima
et al., 2004b), but in triple knock-down embryos some CiAs still
maintain their glycinergic and GABAergic fates.
Discussion
Pax2/8 act redundantly to specify glycinergic and/or GABAergic fates of
many spinal cord interneurons
In this paper, we provide the ﬁrst systematic analysis of the
neurotransmitter fates of all Pax2-expressing spinal interneurons. We
show that in zebraﬁsh embryos, the vast majority of Pax2-expressing
interneurons are glycinergic or GABAergic and these cells account for
∼60% of all glycinergic and GABAergic spinal interneurons and ∼86%
of glycinergic and GABAergic interneurons within the spinal cord
regions where Pax2 is expressed. Studies of speciﬁc subsets of Pax2-
expressing spinal cells in mouse have demonstrated that many of
these neurons are also GABAergic and/or glycinergic (Cheng et al.,
2004; Lewis, 2006 and references therein; Pillai et al., 2007; Sapir
et al., 2004), suggesting that this correlation of Pax2 expression and
glycinergic and GABAergic fates is highly conserved among
vertebrates.
We also show that Pax2a, Pax2b and Pax8 act in a functionally
redundant manner to specify the glycinergic and GABAergic fates of
many Pax2/8-expressing spinal interneurons. When we knock-down
Pax2a, Pax2b and Pax8 many interneurons lose their glycinergic and
GABAergic fates, including the majority of CiAs, which are the most
ventral population of Pax2/8-expressing spinal cells. We also establish
that this function of Pax2/8 in spinal interneurons is very speciﬁc: loss
of Pax2/8 function does not cause cells to change their neurotrans-
mitter phenotype and become excitatory (glutamatergic or choliner-
gic); they are just no longer glycinergic or GABAergic. In addition, at
least in the case of CiAs, their soma shapes and sizes and axon
trajectories are unchanged. It is still formally possible that these
neurotransmitter phenotypes are an indirect effect caused by a lack of
synapse formation and/or synaptic activity in these neurons. However,
given that we observe a dramatic neurotransmitter phenotype as early
as 24 h we consider that this is unlikely.
Our results suggest that the lack of a neurotransmitter phenotype
in ventral Pax2-expressing cells in the mouse Pax2 knock-out, is at
least partly due to redundancy between Pax2 and Pax8. Consistent
with this, in Pax2 mutant mice Pax8 continues to be expressed in the
ventral spinal cord, but it is lost from the Pax2-expressing cells thatmigrate into the dorsal horn (Pillai et al., 2007). This suggests that
Pax2/8 have a major and crucial function in specifying glycinergic and
GABAergic fates of multiple spinal cord interneurons in both the
simple anamniote and the more complex mammalian spinal cord.
As mentioned earlier, Pax2 and Pax8 are part of a subfamily of Pax
transcription factors that also includes Pax5 (Bouchard et al., 2000,
2002; Hans et al., 2004; Holland et al., 2007; Pfeffer et al., 1998; Wada
et al., 1998; Walther et al., 1991). Unlike in zebraﬁsh, in mouse Pax5 is
expressed in the spinal cord (Pillai et al., 2007), raising the possibility
that it may also function redundantly with Pax2 and Pax8 in
mammalian spinal cord.
Other factors must also be involved in specifying glycinergic and
GABAergic spinal fates
While knock-down of Pax2a, Pax2b and Pax8 in zebraﬁsh embryos
results in substantial and statistically signiﬁcant reductions in the
number of spinal interneurons with glycinergic and/or GABAergic
fates, several glycinergic and/or GABAergic spinal interneurons
remain in these triple knock-down embryos. Many of the remaining
GABAergic neurons are located in the very ventral spinal cord (rows
1–3; Fig. 3E) outside the Pax2/8 expression domain (rows 4–7: Fig. 1I)
and, hence, these GABAergic neurons must be speciﬁed by a different
mechanism. However, in addition, a minority of Pax2/8-expressing
cells retain their glycinergic and/or GABAergic fates in triple knock-
down embryos. Interestingly, this is the case even for CiAs, which are
thought to constitute a single class of neurons (Higashijima et al.,
2004b). Furthermore, in triple knock-down embryos the number of
glycinergic cells is reduced much more dramatically than the number
of GABAergic cells. This might suggest that Pax2/8 have a more
pronounced role in specifying glycinergic neurons than GABAergic
neurons. Alternatively Pax2/8 might be required for maintenance of
glycinergic and GABAergic fates rather than their initial speciﬁcation,
as CiAs (and potentially other zebraﬁsh spinal neurons) change from a
GABAergic to a glycinergic fate during their development (Higashijima
et al., 2004b). However, in this case we would expect there to be a
more severe reduction of glycinergic and/or GABAergic neurons in
triple knock-down embryos at later stages, but this is not what we
observe (Supp. Data Figs. 4A and A' and Supp. Data Fig. 5).
One possible explanation for the phenotype not being completely
penetrant might be an incomplete knock-down of Pax2/8 function.
However, in this case any remaining Pax2/8 expression must be very
weak as it is not detected by Pax2 immunohistochemistry or pax8 in
situ hybridisation (Figs. 1F and 3I). Therefore, we think that it is more
likely that, while Pax2/8 are major players in specifying glycinergic
and GABAergic spinal fates, there are other factors that can
compensate for the loss of Pax2/8 in some cells. For example, it is
possible that Pax2/8 may only be required for glycinergic and/or
GABAergic neurotransmitter expression in as-yet-unidentiﬁed distinct
subsets of CiAs and other Pax2/8-expressing cells. Alternatively,
induction of glycinergic and GABAergic fates may be a strongly
bufferedmechanismwhere other transcription factors can sometimes,
in a stochastic manner, substitute for loss of Pax2/8. If this is the case,
then it is not yet clear what these additional, as-yet-unidentiﬁed,
transcription factors might be. In the mouse dorsal horn, Lbx1, Ptf1a,
Lhx1 and Lhx5 transcription factors are also required for correct
speciﬁcation of GABAergic fates. However, all of these proteins act
upstream of Pax2 and control neurotransmitter fates by regulating
pax2 expression (Cheng et al., 2004, 2005; Glasgow et al., 2005; Pillai
et al., 2007) so they are unlikely to compensate for loss of Pax2/8.
Finally, another possible explanation for some Pax2/8-expressing
glycinergic and GABAergic neurons maintaining their neurotransmit-
ter fates is suggested by the observation that spontaneous neuronal
activity can homeostatically bias the speciﬁcation of excitatory versus
inhibitory spinal fates. Experiments in frogs have shown that spinal
cord neurons with particular neurotransmitter fates share speciﬁc
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calcium spikes are blocked by genetic or pharamacological agents
then the number of inhibitory neurons decreases and the number of
excitatory neurons increases, whereas the opposite phenotype is
observed if calcium activity levels are increased (Borodinsky et al.,
2004; Spitzer et al., 2004). Interestingly, the genetic identities of these
cells are unchanged, suggesting that activity levels can, in some
instances, over-ride other developmental cues that specify neuro-
transmitter fates. Spontaneous intracellular calcium signals have also
been observed during early development of zebraﬁsh spinal cord
neurons (Ashworth and Bolsover, 2002). Therefore, the incomplete
loss of glycinergic and GABAergic fates in neurons that normally
express Pax2/8 in triple knock-down embryos could be due to some
glycinergic and GABAergic fates being maintained by this activity-
based mechanism. However, it is not yet clear whether this
mechanism acts upstream, downstream or in parallel to transcription
factor speciﬁcation of neurotransmitter fates. In addition, in these
experiments neurons either switched their fates (from inhibitory to
excitatory or vice versa) or, in a small number of cases, they co-
expressed excitatory and inhibitory neurotransmitters (Borodinsky
et al., 2004), whereas in Pax2/8 triple knock-down experiments many
neurons lose their glycinergic and GABAergic fates, but they do not
acquire glutamatergic or cholinergic fates.
Pax2/8 are not sufﬁcient to specify glycinergic or GABAergic fates
While about 90% of Pax2/8-expressing spinal interneurons are
either glycinergic or GABAergic at 24 h, only ∼60% are glycinergic and
∼60% are GABAergic. In addition, a minority of Pax2/8-expressing cells
in both zebraﬁsh andmouse dorsal spinal cords express glutamatergic
markers (Figs. 2C and E; Cheng et al., 2004). This suggests that while
Pax2/8 are required for glycinergic and GABAergic fates in many cells,
expression of these transcription factors is not sufﬁcient to specify one
or other of these neurotransmitter fates. This is consistent with data
reported in chick, where ectopic expression of Pax2 in the neural tube
did not induce GABA expression (Cheng et al., 2004).
It is not clear from our results why some Pax2/8-expressing cells
are glycinergic, some are GABAergic and some express both of these
neurotransmitters. It is possible that at least some of the GABAergic
cells or the cells expressing both GABA and glycine will later become
glycinergic as has been suggested for CiAs (Higashijima et al., 2004b).
Therefore, at least some of these differences in neurotransmitter fates
may reﬂect a temporal progression within particular neurons from
(GABAergic) to (GABAergic and glycinergic) to (glycinergic). Consis-
tent with this, the number of glycinergic neurons more than doubles
between 24 h and 48 h whereas the number of GABAergic neurons
stays pretty much constant (Supp. Data. Figs. 4A and A'). However, it
is also possible that in at least some cases, these different
neurotransmitter fates reﬂect more profound differences between
cells. In this case, these differences may result from differential
expression of other transcription factors or different developmental
histories.
The simplest explanation for the Pax2/8-expressing glutamatergic
cells would be that there is another transcription factor expressed in
these cells that inhibits the function of Pax2/8 and instead speciﬁes a
glutamatergic phenotype. There is a precedence for this type of
mechanism, in that the Lbx1 transcription factor normally speciﬁes
GABAergic interneurons in the dorsal spinal cord, but in a subset of
Lbx1-expressing cells, Tlx3 inhibits the function of Lbx1 and induces a
glutamatergic phenotype (Cheng et al., 2005).
Speciﬁcity of the Pax2/8 triple knock-down phenotype
One of the potentially surprising aspects of our results is the
speciﬁcity of the phenotype that we observe in the absence of
Pax2/8 function. While we cannot rule out that additional pheno-types develop at later stages in the neurons that normally express
Pax2/8 in triple knock-down embryos (and it would be hard to test
this using morpholinos as their efﬁcacy decreases with increasing
age of the embryos and dilution of the morpholinos), the only
phenotype that we have identiﬁed so far in these neurons is a loss of
glycinergic and GABAergic fates. This might initially be surprising,
given that, as discussed above, neuronal activity can homeostatically
adjust neurotransmitter fates in the spinal cord (Borodinsky et al.,
2004) and given a recent report that knocking-down glycine
receptors reduces the number of neurons (including Pax2-expressing
neurons) in the zebraﬁsh spinal cord (McDearmid et al., 2006).
However, with respect to the former study, the speciﬁcation of
neurotransmitter fates by calcium activity is thought to be cell
autonomous (so defects in a subset of spinal neurons shouldn't affect
other neurons) and in the case of the latter study, decreases in
neuronal numbers were only observed at later stages of develop-
ment. While neuronal morphology was not examined in the mouse
Pax2 mutant dorsal horn, these studies also observed that the cells
that lost GABAergic fates did not become glutamatergic, suggesting
that the speciﬁcity of the Pax2/8 phenotype may be highly conserved
between different vertebrates.
Functional consequences of loss of Pax2/8
In zebraﬁsh, the only Pax2/8-expressing interneurons that have
been identiﬁed morphologically or functionally are CiAs (this report).
These are genetically and functionally homologous to mammalian V1
cells (Alvarez et al., 2005; Higashijima et al., 2004b; Sapir et al.,
2004; Saueressig et al., 1999). However, comparisons with amniotes
suggest that more dorsal Pax2/8-expressing interneurons in the
zebraﬁsh spinal cord are likely to be functionally equivalent to
amniote V0, dI6, dI4 and/or DILA interneurons (Lewis, 2006 and
references therein). Of these neurons, DILA neurons migrate into the
superﬁcial lamina of the dorsal horn where they are probably
involved in nociception, dI4 cells are thought to migrate into deeper
layers of the dorsal horn and V1, V0 and dI6 interneurons form part
of the locomotion central pattern generator in the ventral spinal
cord. At least a subset of V0 interneurons are essential in mice for
correct walking movements as they control the alternating left–right
activity of the motor neurons that innervate hindlimb muscles
(Lanuza et al., 2004). In contrast, V1 cells are required for fast
locomotion in mouse: if these cells are genetically ablated or
temporarily inactivated, mice are unable to walk at fast speeds but
they can still walk at slower speeds (Gosgnach et al., 2006). This is also
consistent with data from tadpoles, which shows that aINs (which are
genetically homologous to both CiAs and V1 cells) provide early cycle
inhibition to central pattern generator neurons during swimming,
particularly at faster swimming frequencies (Li et al., 2004). Based on
these results in other vertebrates, we would predict that altering the
neurotransmitter phenotypes of Pax2/8-expressing cells might have
functional consequences both for sensory processing and correct
locomotion.
Unfortunately, this is not easy to assess in our experiments, as we
can't distinguish between behavioural defects due to the spinal cord
phenotype that we describe in this paper and behavioural defects due
to previously described brain phenotypes (for example even noi single
mutant embryos lack a midbrain–hindbrain boundary";; Brand et al.,
1996; Lun and Brand, 1998). However, we do observe considerable
locomotion defects in triple knock-down embryos. For example, triple
knock-down embryos only move when they are poked (even at stages
where wild-type embryos undergo spontaneous fast swimming
movements), a signiﬁcant percentage of triple knock-down embryos
don't move at all (5/20 at 24 h, 3/20 at 48 h) and an even larger
percentage swim in circles (8/20 at 48 h), or vibrate on the spot (6/20
at 48 h) when poked. All of this is at least consistent with the idea that
locomotion control is perturbed in these embryos.
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Taken together, all of these results suggest that Pax2/8 transcrip-
tion factors have crucial but redundant functions in specifying the
glycinergic and GABAergic fates of multiple spinal interneurons in
both the simple anamniote and the more complex mammalian spinal
cord. Comparisons between zebraﬁsh, Xenopus and mouse have
suggested that mechanisms of spinal cord patterning and resulting
neuronal circuitry might be highly conserved in vertebrates, with
distinct functional classes of interneurons being speciﬁed by different
combinations of post-mitotically expressed transcription factors
(Goulding and Pfaff, 2005; Lewis, 2006). However, to our knowledge,
our study is the ﬁrst that has demonstrated that some of these post-
mitotically expressed transcription factors, do indeed have similar
functions in anamniote and mammalian spinal cord interneurons.Acknowledgments
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